Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention

Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction

(2020) Peter Sinnaeve et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

(2019) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

(2019) Roxana Mehran et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery

(2018) Roberta Rossini et al.   JACC-Cardiovascular Interventions

Early myocardial surgical revascularization after ST-segment elevation myocardial infarction in multivessel coronary disease

(2018) Maria V. Polito et al.   Journal of Cardiovascular Medicine

Cangrelor use prior to left ventricular assist device surgery: a case series

(2018) Jeffrey B. Washam et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy

(2018) Jae Youn Moon et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series

(2018) Stephanie Bowman et al.   ANNALS OF PHARMACOTHERAPY

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Cangrelor Use in Cardiogenic Shock

(2017) Muthiah Vaduganathan et al.   JACC-Cardiovascular Interventions

Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography–Guided Percutaneous Coronary Intervention With Stent Implantation

(2017) Sergio Buccheri et al.   JACC-Cardiovascular Interventions

Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery

(2017) Subhash Banerjee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis

(2017) Elizabeth A. Walker et al.   PHARMACOTHERAPY

The Incremental Risk of Coronary Stents on Postoperative Adverse Events

(2016) Carla N. Holcomb et al.   ANNALS OF SURGERY

Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery

(2016) Ehrin J. Armstrong et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation

(2016) Gro Egholm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

(2016) Glenn N. Levine et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients

(2016) Nathan H. Waldron et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients

(2016) Stefano De Servi et al.   VASCULAR PHARMACOLOGY

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

(2015) Philip Urban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: A weighted meta-analysis of 280 patients from eight studies

(2014) Jeremy Warshauer et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery

(2013) Davide Capodanno et al.   CIRCULATION

Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction

(2013) Jing-Gang Xia et al.   CORONARY ARTERY DISEASE

Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents

(2013) Mary T. Hawn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events

(2013) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration

(2013) Laith I. Alshawabkeh et al.   EuroIntervention

Safety of “Bridging” With Eptifibatide for Patients With Coronary Stents Before Cardiac and Non-Cardiac Surgery

(2012) Andrew N. Rassi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes

(2012) George D. Dangas et al.   JACC-Cardiovascular Interventions

Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery

(2012) Dominick J. Angiolillo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Perioperative Management of Patients on Clopidogrel (Plavix) Undergoing Major Lung Resection

(2011) DuyKhanh P. Ceppa et al.   ANNALS OF THORACIC SURGERY

Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents

(2011) T. Ben Morrison et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery

(2011) S. SAVONITTO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation

(2011) E. G. Marcos et al.   Netherlands Heart Journal

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel

(2010) S. Savonitto et al.   BRITISH JOURNAL OF ANAESTHESIA

Previous Coronary Stent Implantation and Cardiac Events in Patients Undergoing Noncardiac Surgery

(2010) Nicholas L.M. Cruden et al.   Circulation-Cardiovascular Interventions

Frequency of Major Noncardiac Surgery and Subsequent Adverse Events in the Year After Drug-Eluting Stent Placement

(2010) Peter B. Berger et al.   JACC-Cardiovascular Interventions

Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy

(2010) Maurizio DʼUrbano et al.   Journal of Cardiovascular Medicine

Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent Use

(2009) Saif Anwaruddin et al.   JACC-Cardiovascular Interventions

Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist

(2009) Wendell S. Akers et al.   JOURNAL OF CLINICAL PHARMACOLOGY